Материалов:
1 005 012

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 8382

Страница 4 из 839

Пожилые пациенты в рандомизированных клинических исследованиях: этические аспекты
Бутранова О.И., Зырянов С.К.
, expressed in their insufficient inclusion or non-inclusion in randomized clinical trials. As a result
Systematic review: Pharmacological interventions for the treatment of post-stroke fatigue
Chu, Shuk Han, Zhao, Xu, Komber, Ahmad, Cheyne, Joshua, Wu, Simiao, Cowey, Eileen, Kutlubaev, Mansur, Mead, Gillian
reviews of randomized controlled trials found insufficient evidence to guide practice, but most excluded
Letters to the Editor
Jargin S.V.
randomized controlled trial (topic)
Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan
Sarsenbayeva G.
II on healthy subjects up to 60 years. Methods: The trial involved 150 subjects in randomized 2
Succinate-Based Dietary Supplement for Menopausal Symptoms: A Pooled Analysis of Two Identical Randomized, Double-Blind, Placebo-Controlled Clinical Trials
Radzinsky V.E., Uspenskaya Y., Shulman L.P., Kuznetsova I.V.
randomized, double-blinded clinical trial. © 2019 Viktor E. Radzinsky et al.
Volar Locking Plate versus Closed Reduction and Immobilization for Distal Radius Fracture in the Elderly: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Latypov N., Golubev I., Borisova A.
A systematic review and meta-analysis of randomized controlled trials was conducted to compare
Optimization of arterial hypertension management by the use of two- and three-drugs fixed dose combinations at the daily stay department
Kobalava Zh.D., Kotovskaya Yu.V., Lobzhanidze T.V., Kravtsova O.A.
randomized controlled trial
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Logunov D.Y., Dolzhikova I.V., Shcheblyakov D.V., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S., Kovyrshina A.V., Lubenets N.L., Grousova D.M., Erokhova A.S., Botikov A.G., Izhaeva F.M., Popova O., Ozharovskaya T.A., Esmagambetov I.B., Favorskaya I.A., Zrelkin D.I., Voronina D.V., Shcherbinin D.N., Semikhin A.S., Simakova Y.V., Tokarskaya E.A., Egorova D.A., Shmarov M.M., Nikitenko N.A., Gushchin V.A., Smolyarchuk E.A., Zyryanov S.K., Borisevich S.V., Naroditsky B.S., Gintsburg A.L., Gam-COVID-Vac Vaccine Trial Group
at ClinicalTrials.gov (NCT04530396). Findings: Between Sept 7 and Nov 24, 2020, 21 977 adults were randomly
Double-blind randomized placebocontrolled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: Implications for cervical cancer prevention
Ashrafian L., Sukhikh G., Kiselev V., Paltsev M., Drukh V., Kuznetsov I., Muyzhnek E., Apolikhina I., Andrianova E.
Background: The article presents the results of a clinical trial on the efficacy and safety of a
Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials
Zangrillo Alberto
2015. Randomized trials on the use of levosimendan in patients with severe sepsis and septic shock were

Страница 4 из 839

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core